ADAG

Adagene (ADAG)

About Adagene (ADAG)

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Details

Daily high

$3.74

Daily low

$3.40

Price at open

$3.62

52 Week High

$4.75

52 Week Low

$1.30

Market cap

169.6M

Dividend yield

0.00%

Volume

103,468

Avg. volume

219,958

P/E ratio

-9.57

Adagene News